Home
>
National Drug Code (NDC)
>
LANEIGE SATIN FINISH TWIN PACT NO. 23
LANEIGE SATIN FINISH TWIN PACT NO. 23 - 43419-865-42 - (TITANIUM DIOXIDE, OCTINOXATE, and ZINC OXIDE)
Drug Information of LANEIGE SATIN FINISH TWIN PACT NO. 23
| Product NDC: | 43419-865 |
| Proprietary Name: | LANEIGE SATIN FINISH TWIN PACT NO. 23 |
| Non Proprietary Name: | TITANIUM DIOXIDE, OCTINOXATE, and ZINC OXIDE |
| Active Ingredient(s): | .06; .08; .0294 mg/g; mg/g; mg/g & nbsp; TITANIUM DIOXIDE, OCTINOXATE, and ZINC OXIDE |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | POWDER |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of LANEIGE SATIN FINISH TWIN PACT NO. 23
| Product NDC: | 43419-865 |
| Labeler Name: | AMOREPACIFIC |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part352 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20101201 |
Package Information of LANEIGE SATIN FINISH TWIN PACT NO. 23
| Package NDC: | 43419-865-42 |
| Package Description: | 13 g in 1 CONTAINER (43419-865-42) |
NDC Information of LANEIGE SATIN FINISH TWIN PACT NO. 23
| NDC Code | 43419-865-42 |
| Proprietary Name | LANEIGE SATIN FINISH TWIN PACT NO. 23 |
| Package Description | 13 g in 1 CONTAINER (43419-865-42) |
| Product NDC | 43419-865 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | TITANIUM DIOXIDE, OCTINOXATE, and ZINC OXIDE |
| Dosage Form Name | POWDER |
| Route Name | TOPICAL |
| Start Marketing Date | 20101201 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | AMOREPACIFIC |
| Substance Name | OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE |
| Strength Number | .06; .08; .0294 |
| Strength Unit | mg/g; mg/g; mg/g |
| Pharmaceutical Classes |
